Biosimilars

Featured Article
Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations for the successful adoption of biosimilars, and highlight…
Identifying Pharmacist Knowledge of a Medication Drug Type
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of…

Newsfeed

Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
Identifying Pharmacist Knowledge of a Medication Drug Type
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
Biosimilar Infliximab Appears Effective in Crohn's Disease
Roche Wins Reprieve as Novartis Biosimilar Delayed in U.S.
Pharma Trends: Generic Drugs in Race to the Bottom, Biosimilars Fail to Launch
Switching to Biosimilars: The Long Road to Savings
AbbVie, Samsung Bioepis in Deal; Humira Biosimilar U.S. Release in 2023
View More

Insights

Switching to Biosimilars: The Long Road to Savings
In this blog, Russel J Spjut, owner of Formulary Intel Consulting, discusses how biosimilars have delivered a false hope of price reductions comparable to generic drugs.
View More

Interactive Features

Identifying Pharmacist Knowledge of a Medication Drug Type
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
View More
Back to Top